These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9741512)

  • 21. Does gender bias exist in the medical management of heart failure?
    Harjai KJ; Nunez E; Stewart Humphrey J; Turgut T; Shah M; Newman J
    Int J Cardiol; 2000 Aug; 75(1):65-9. PubMed ID: 11054508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
    Pitt B
    Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the clinical effect between digoxin and a diuretic in chronic left heart failure and sinus rhythm].
    Vöhringer HF; Schüren KP
    Med Klin (Munich); 1993 Jul; 88(7):410-6. PubMed ID: 8377718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure.
    Cataliotti A; Boerrigter G; Chen HH; Jougasaki M; Costello LC; Tsuruda T; Lee SC; Malatino LS; Burnett JC
    Circulation; 2002 Feb; 105(5):639-44. PubMed ID: 11827932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
    Benatar D; Hall V; Reddy S; Gheorghiade M
    Am J Ther; 1998 Jan; 5(1):25-32. PubMed ID: 10099034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The main aspects of symptomatic therapy of chronic heart failure].
    Zaliaduonyte-Peksiene D; Mikuckaite L; Kavoliūniene A
    Medicina (Kaunas); 2006; 42(11):949-55. PubMed ID: 17172798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there an expanded role for digoxin in patients with heart failure and sinus rhythm? A protagonist viewpoint.
    Williamson KM; Patterson JH
    Ann Pharmacother; 1997; 31(7-8):888-92. PubMed ID: 9220052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of heart failure: implications of the recent European Society of Cardiology Guidelines for the older patient.
    Gillespie ND; McMurdo ME; Struthers AD
    Age Ageing; 2003 Nov; 32(6):563-5. PubMed ID: 14599994
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.
    Khan MS; Fonarow GC; Ahmed A; Greene SJ; Vaduganathan M; Khan H; Marti C; Gheorghiade M; Butler J
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitors in heart failure: new strategies justified by recent clinical trials.
    Young JB
    Int J Cardiol; 1994 Feb; 43(2):151-63. PubMed ID: 8181869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications during enalapril and diuretic therapy for congestive cardiac failure.
    Mehta S; Vijayakumar M
    Indian J Pediatr; 2009 Sep; 76(9):963-4. PubMed ID: 19904515
    [No Abstract]   [Full Text] [Related]  

  • 37. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES).
    Pitt D
    Eur Heart J; 1995 Dec; 16 Suppl N():107-10. PubMed ID: 8682055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors.
    Kula S; Tunaoglu FS; Olgunturk R; Gokcora N
    Can J Cardiol; 2003 Mar; 19(4):405-8. PubMed ID: 12704487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
    van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.